Nicotine Eg

Nicotine, the active ingredient in Nicotine Eg, is a nicotine replacement therapy presented as a transdermal patch for transdermal use. Classified under ATC code N07BA02, it is intended for adult smokers seeking to reduce withdrawal symptoms during cessation attempts. The patch delivers nicotine steadily through the skin to alleviate cravings.

GNH USA supplies Nicotine Eg as a licensed, GDP‑compliant supplier serving hospitals, pharmacies and clinics worldwide, ensuring regulatory compliance and timely delivery for markets across the European Union and other regions.

Nicotine Eg is a nicotine replacement therapy used to aid smoking cessation by delivering nicotine through the skin.

- Smoking cessation: helps reduce withdrawal symptoms and cravings during quit attempts. - Tobacco dependence: supports gradual reduction of nicotine intake. - Relapse prevention: assists in maintaining abstinence after quitting.

Nicotine Eg may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Skin irritation at the application site: redness, itching, or mild rash. - Sleep disturbance: insomnia or vivid dreams. - Nausea or mild gastrointestinal upset. - Headache.

Serious or Rare Side Effects: - Allergic reaction: swelling, hives, or severe rash. - Cardiovascular events: tachycardia, hypertension, or chest pain.

Before using Nicotine Eg, consider the following safety measures.

- Cardiovascular assessment: evaluate for recent myocardial infarction or uncontrolled hypertension. - Concomitant nicotine: avoid using other nicotine products to prevent overdose. - Pregnancy and lactation: discuss risks with a healthcare professional; safety data are limited. - Child safety: keep patches out of reach of children and pets. - Storage: Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Nicotine Eg can interact with certain medicines; monitor the following.

Major Interactions (Avoid): - Use with other nicotine replacement products: risk of nicotine toxicity. - Concurrent smoking of tobacco while using the patch: may lead to excessive nicotine levels.

Moderate Interactions (Monitor Closely): - Beta‑blockers: nicotine may blunt antihypertensive effects. - Cimetidine or other CYP2A6 inhibitors: may increase nicotine plasma concentrations. - Theophylline: nicotine can enhance theophylline side effects such as tremor or palpitations.